Assessment of Quality of Life of Chronic Myeloid Leukemia Patients by Using the EORTC QLQ-C30.
作者信息
Uğur Mehmet Can, Kutbay Yaşar Bekir, Özer Kaya Özge, Ceylan Cengiz
机构信息
Tepecik Training and Research Hospital, Clinic of Internal Medicine, İzmir, Turkey, Phone: +90 505 886 11 26 E-mail:
出版信息
Turk J Haematol. 2017 Jun 5;34(2):197-199. doi: 10.4274/tjh.2016.0409. Epub 2016 Dec 30.
Abstract
摘要
相似文献
1
Assessment of Quality of Life of Chronic Myeloid Leukemia Patients by Using the EORTC QLQ-C30.
Turk J Haematol. 2017 Jun 5;34(2):197-199. doi: 10.4274/tjh.2016.0409. Epub 2016 Dec 30.
2
Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia.EORTC QLQ-CML24 问卷评估慢性髓性白血病患者健康相关生活质量的验证和参考值。
Leuk Lymphoma. 2021 Mar;62(3):669-678. doi: 10.1080/10428194.2020.1838509. Epub 2020 Nov 6.
3
Treatment of CML using IFN-alpha: impact on quality of life.
Hematol J. 2003;4(4):253-62. doi: 10.1038/sj.thj.6200251.
4
Health state utility and quality of life measures in patients with chronic myeloid leukemia in France.法国慢性髓性白血病患者的健康状态效用和生活质量测量。
Qual Life Res. 2021 Jul;30(7):2021-2032. doi: 10.1007/s11136-021-02794-5. Epub 2021 Mar 2.
5
A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase.同胞异基因造血干细胞移植治疗慢性髓系白血病慢性期的长期生活质量状况单中心评估
Bone Marrow Transplant. 2004 Sep;34(6):545-56. doi: 10.1038/sj.bmt.1704638.
6
The impact of new generic formulations of imatinib mesylate on general quality of life in chronic phase chronic myeloid leukaemia patients.甲磺酸伊马替尼新通用制剂对慢性期慢性髓性白血病患者总体生活质量的影响。
Eur J Cancer Care (Engl). 2017 Mar;26(2). doi: 10.1111/ecc.12423. Epub 2015 Nov 23.
7
Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group.哪些与健康相关的生活质量方面对于接受靶向治疗的慢性髓性白血病患者和医疗保健专业人员很重要？意大利 GIMEMA 和 EORTC 生活质量小组。
Ann Hematol. 2012 Sep;91(9):1371-81. doi: 10.1007/s00277-012-1458-6. Epub 2012 Apr 29.
8
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib.慢性疲劳是接受伊马替尼治疗的慢性髓性白血病患者健康相关生活质量的最重要限制因素。
Leukemia. 2013 Jul;27(7):1511-9. doi: 10.1038/leu.2013.51. Epub 2013 Feb 18.
9
Isolated polyglobulia as an uncommon presentation of chronic myeloid leukaemia.孤立性红细胞增多作为慢性髓系白血病的一种罕见表现。
Blood Cells Mol Dis. 2016 Jan;56(1):37. doi: 10.1016/j.bcmd.2015.10.008. Epub 2015 Oct 28.
10
[Bcr-abl fusion gene-positive chronic myeloid leukemia secondary to extramedullary T lymphoblastic disease: a case report and literature review].[髓外T淋巴细胞母细胞疾病继发Bcr-abl融合基因阳性慢性髓性白血病：1例报告并文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2011 Oct;32(10):693-4.
引用本文的文献
1
Quality of life among chronic myeloid leukemia patients in the second-line treatment with nilotinib and influential factors.尼洛替尼二线治疗慢性髓性白血病患者的生活质量及其影响因素。
Qual Life Res. 2022 Mar;31(3):733-743. doi: 10.1007/s11136-021-02952-9. Epub 2021 Jul 14.
本文引用的文献
1
Depression and anxiety disorders in palliative cancer care.姑息性癌症护理中的抑郁症和焦虑症。
J Pain Symptom Manage. 2007 Feb;33(2):118-29. doi: 10.1016/j.jpainsymman.2006.07.016.
2
The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.欧洲癌症研究与治疗组织QLQ-C30：对欧洲癌症研究与治疗组织QLQ-C30土耳其语版本的文化效度和信度的考察。
Eur J Cancer Care (Engl). 2004 May;13(2):135-44. doi: 10.1111/j.1365-2354.2003.00435.x.
3
Depression in palliative care patients--a prospective study.
Eur J Cancer Care (Engl). 2001 Dec;10(4):270-4. doi: 10.1046/j.1365-2354.2001.00290.x.
Zotero 插件